Healthcare & Biotech

Friendswood, Texas – September 24, 2026 -- More than half of atopic dermatitis (AD) patients who used targeted systemic therapies modified treatment because the drugs failed to work, according to a new study published in Dermatology and Therapy by Castle Biosciences, Inc. (Nasdaq: CSTL).

Study finds 55% of systemic therapy users switched due to lack of efficacy

The research surveyed 43 AD patients and caregivers who completed a 32-question assessment at the 2024 National Eczema Association Eczema Expo. Among respondents who had used targeted systemic therapies, 55% reported modifying treatment because of insufficient results. Inadequate skin clearance and persistent itching were cited as the most frequent reasons for switching drugs or adding topical treatments.

New York City – September 24, 2026 -- NYU Langone Health has recruited three senior orthopedic surgeons -- Dr. Sabrina M. Strickland, Dr. F. Winston Gwathmey, and Dr. Andreas H. Gomoll -- to lead new specialty centers within its orthopedics division, currently ranked No. 2 nationally by U.S. News & World Report.

NYU Langone builds out joint-preservation leadership with three senior hires

Dr. Strickland arrives from the Hospital for Special Surgery in Manhattan, where she practiced for more than two decades, to become the inaugural director of NYU Langone's new Center for Patellofemoral Disorders. Her clinical focus spans knee cartilage repair, patellar stabilization, ACL and meniscus surgery, and joint preservation; she also uses 3D-printed joint models to refine surgical techniques for patients with atypical bone structures, addressing a gap left by biomechanical research that relies primarily on cadaveric 'normal' joints.

Irving, Texas – – September 24, 2026 -- The Inner Circle has named Dr. Lee Campbell Drinkard, MD, FACP, a Pinnacle Lifetime Member for his career in hematology, oncology and palliative care.

Drinkard practices locum tenens across multiple states, treating malignant and benign tumors

Dr. Drinkard currently works as a locum tenens physician, traveling nationwide to consult on complex hematology and oncology cases, including both malignant and benign tumors. His practice also extends to hospice and palliative care for patients managing life-limiting illness.

Drinkard holds four board certifications spanning internal medicine to palliative care

He is board certified in internal medicine, hematology, oncology, and hospice and palliative care. Drinkard is also a Fellow of the American College of Physicians, the credential reflected in his FACP designation.

Menlo Park, Calif. – September 24, 2026 -- MyOme, Inc. has made its predictive genomic insights platform and testing services available worldwide by running them on Oracle Cloud Infrastructure (OCI), the companies announced.

MyOme joins Oracle PartnerNetwork to widen healthcare distribution

The clinical whole-genome analysis firm has also joined Oracle PartnerNetwork (OPN), enabling distribution of its capabilities through the Oracle ecosystem and Oracle Marketplace to a broader base of healthcare organizations.

Washington – September 24, 2026 -- More than half of US adults did not attempt to get a flu, COVID-19, RSV, or pneumococcal vaccine in the past year, even though 77% agree vaccines are among the best proven tools against serious infectious disease, according to a new national survey released by the National Foundation for Infectious Diseases (NFID).

Survey finds 48% of adults tried to get at least one of four respiratory vaccines in the past year

The survey, conducted by NORC at the University of Chicago among 1,206 US adults age 18 and older between August 13-17, 2026, has a margin of sampling error of ±3.6 percentage points. Just 44% tried to get a flu vaccine and only 23% attempted a COVID-19 vaccine, despite 89% of respondents agreeing that anyone who wants vaccine access should have it and 71% saying benefits strongly outweigh risks.

Washington – September 24, 2026 -- Moore has been named brand agency of record for the Alzheimer's Association, expanding an existing fundraising mandate to now cover strategy, creative and media across the health organization's master brand.

Moore expands scope beyond fundraising into full brand management

The appointment follows a competitive review process and grants Moore oversight of all brand creative development, paid media planning and delivery, and marketing across the Association's master brand and national initiatives. The agency will also support select medical and scientific research communications, product launches, and campaigns aimed at reinforcing the Association's position in brain health.

Washington – September 24, 2026 -- The Leapfrog Group, a national watchdog organization of employers and other health care purchasers, has elected Raquel Bono, MD, MBA, FACS, as its new Board Chair, marking the first time a surgeon has led the nonprofit's board.

Retired Navy Vice Admiral brings $50 billion health system oversight to Leapfrog's board

Dr. Bono is a board-certified trauma surgeon and retired three-star Vice Admiral in the U.S. Navy, where she served as the 11th Chief of the Navy Medical Corps. From 2015 to 2019, she directed the Defense Health Agency, overseeing integration of a $50 billion global health system serving millions of service members and their families.

Guangzhou – September 24, 2026 -- Pomdoctor Limited (NASDAQ: POM) outlined a differentiated "hardware plus AI plus payment" infrastructure model that it says sets the company apart from traditional internet healthcare platforms, which typically operate in silos around discrete services such as online consultations or pharmaceutical transactions.

Pomdoctor targets full-cycle predictive healthcare integration

The Guangzhou-based digital healthcare company said its system is designed to combine continuous health monitoring, AI-powered analysis, physician intervention, healthcare payment and fulfillment into a single closed-loop ecosystem, rather than offering standalone services.

Boulder, Colo. – September 24, 2026 -- Ultimate Longevity Center (ULC), a Sequel Brands franchise with more than 300 territories sold globally, will host two free live events with human performance expert Gary Brecka in Colorado on Sunday, October 4.

ULC schedules back-to-back Colorado events after strong Los Angeles turnout

Brecka will appear at Macky Auditorium in Boulder at 10:30 AM MT and at the Fillmore Auditorium in Denver at 3:30 PM MT, both hosted by ULC in collaboration with Ultimate Human. The dates follow his August appearance at Peacock Theater in Los Angeles, which drew thousands of attendees.

Newport Beach – September 23, 2026 -- Ultimate Longevity Center (ULC) has surpassed 300 sold territories worldwide after unveiling a 50-location Australian franchise rollout, with the first center confirmed for Sydney's Double Bay in Q1 2027.

ULC crosses 300 global territories within a year of launching U.S. franchise sales

The longevity and human-optimization brand, built by Sequel Brands founder Anthony Geisler alongside human biologist Gary Brecka and precision health platform Lifeforce, has sold more than 275 territories across the United States since opening franchise sales in 2026, including 200 in its first four months. The newly announced 50-center Australian network pushes the brand's global footprint past 300 territories.